Michael Woudenberg - Feb 23, 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
SVP, Chem/Manufacturing/Control
Signature
/s/ Bruce Colwill, attorney-in-fact for Mr. Michael Woudenberg
Stock symbol
INM
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 01:20 PM
Previous filing
Oct 19, 2021
Next filing
Nov 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +5K +5.49% $0.00 96.1K Feb 23, 2022 Common shares 5K $1.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 2/23/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.

Remarks:

SVP, Chem/Manufacturing/Control